Bangladesh signs agreement with Serum Institute of India for procuring COVID-19 vaccine


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Bangladesh signs agreement with Serum Institute of India for procuring COVID-19 vaccine
Bangladesh government is also in talks with other countries to procure more doses of the COVID-19 vaccine

Health Minister Zahed Maleq told the media after the signing of the agreement that the vaccine has proved safe during trials in different countries and it is suitable for Bangladesh, reports the news agency UNB. He said the government is also in talks with other countries to procure more doses of the COVID-19 vaccine.

According to the agreement with the Serum Institute of India (SII) for procurement of 3 crore doses of the Oxford/ Astrazeneca vaccine. The vaccine will be delivered in six instalments of 50 lakh doses each.

Earlier, on November 15, a tripartite MoU was signed between SII, Bangladesh pharmaceutical company Beximco Pharmaceuticals Ltd (BPL) and the government of Bangladesh for the procurement of the Oxford/Astrazeneca COVID-19 vaccine.

In the meanwhile, Bangladesh reported 32 more deaths due to Coronavirus on Sunday taking the death toll to 7052. According to the latest figures released by the Directorate General of Health Services (DGHS), 1355 new cases and 3393 recoveries were also reported over the last 24 hours. The total number of people infected by Coronavirus in Bangladesh now stands at 4.9 lakh. Recovery rate in the country is 85.80 per cent.

Tags : #Bangladesh #LatestNewsonCOVIDVaccine14thDec #SerumInstituteofIndia #OxfordAstrazeneca #COVID-19Pandemic #Unite2FightCorona #Deaths #RecoveryRate

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026